Entry  
 
Name  
Non-alcoholic fatty liver disease - Neogale vison (American mink)
 
Description  
Non-alcoholic fatty liver disease (NAFLD) represents a spectrum ranging from simple steatosis to more severe steatohepatitis with hepatic inflammation and fibrosis, known as nonalcoholic steatohepatitis (NASH). NASH may further lead to cirrhosis and hepatocellular carcinoma (HCC). This map shows a stage-dependent progression of NAFLD. In the first stage of NAFLD, excess lipid accumulation has been demonstrated. The main cause is the induction of insulin resistance, which leads to a defect in insulin suppression of free fatty acids (FAAs) disposal. In addition, two transcription factors, SREBP-1c and PPAR-alpha, activate key enzymes of lipogenesis and increase the synthesis of FAAs in liver. In the second stage, as a consequence of the progression to NASH, the production of reactive oxygen species (ROS) is enhanced due to oxidation stress through mitochondrial beta-oxidation of fatty acids and endoplamic reticulum (ER) stress, leading to lipid peroxidation. The lipid peroxidation can further cause the production of cytokines (Fas ligand, TNF-alpha, IL-8 and TGF), promoting cell death, inflammation and fibrosis. The activation of JNK, which is induced by ER stress, TNF-alpha and FAAs, is also associated with NAFLD progression. Increased JNK promotes cytokine production and initiation of HCC. 
 
Class  
Human Diseases; Endocrine and metabolic disease 
BRITE hierarchy 
 
Pathway map  
nvs04932   Non-alcoholic fatty liver disease 
 
Disease  
H01333   Non-alcoholic fatty liver disease 
 
Organism  
Neogale vison (American mink) [GN:
nvs ]
 
Gene  
122889330   NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580 ] 
122890557   NDUFA2; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 [KO:K03946 ] 
122891108   NDUFA9; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial [KO:K03953 ] 
122891254   PRKAG1; 5'-AMP-activated protein kinase subunit gamma-1 isoform X1 [KO:K07200 ] 
122891482   NDUFA4L2; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2 [KO:K03948 ] 
122891747   NDUFA12; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 [KO:K11352 ] 
122891864   NDUFA6; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 [KO:K03950 ] 
122891883   ATF4; cyclic AMP-dependent transcription factor ATF-4 [KO:K04374 ] 
122892035   PPARA; peroxisome proliferator-activated receptor alpha [KO:K07294 ] 
122892505   TNFRSF1A; tumor necrosis factor receptor superfamily member 1A [KO:K03158 ] 
122893967   EIF2S1; eukaryotic translation initiation factor 2 subunit 1 [KO:K03237 ] 
122894329   NDUFS4; NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial [KO:K03937 ] 
122894479   NDUFB1; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1 [KO:K03957 ] 
122895803   MLXIPL; carbohydrate-responsive element-binding protein isoform X1 [KO:K09113 ] 
122895963   RAC1; ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392 ] 
122896151   NDUFS6; NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial isoform X1 [KO:K03939 ] 
122896181   NDUFB10; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 [KO:K03966 ] 
122896387   SDHA; succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial isoform X1 [KO:K00234 ] [EC:1.3.5.1 ] 
122897149   NDUFA1; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 [KO:K03945 ] 
122897625   NDUFB11; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial [KO:K11351 ] 
122899425   PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922 ] [EC:2.7.1.153 ] 
122899501   SDHB; succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial [KO:K00235 ] [EC:1.3.5.1 ] 
122899548   CDC42; cell division control protein 42 homolog isoform X1 [KO:K04393 ] 
122899787   NDUFS5; NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 [KO:K03938 ] 
122899916   PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649 ] 
122900404   PRKAB2; 5'-AMP-activated protein kinase subunit beta-2 isoform X1 [KO:K07199 ] 
122900656   FAS; tumor necrosis factor receptor superfamily member 6 [KO:K04390 ] 
122901022   NDUFB8; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial [KO:K03964 ] 
122901740   PRKAG3; 5'-AMP-activated protein kinase subunit gamma-3 [KO:K07200 ] 
122902186   NDUFB3; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 [KO:K03959 ] 
122902465   NDUFA10; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial [KO:K03954 ] 
122903371   PRKAB1; 5'-AMP-activated protein kinase subunit beta-1 [KO:K07199 ] 
122904311   NDUFB9; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 [KO:K03965 ] 
122905031   NDUFA5; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 [KO:K03949 ] 
122905137   NDUFB2; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial [KO:K03958 ] 
122905216   PRKAG2; 5'-AMP-activated protein kinase subunit gamma-2 isoform X1 [KO:K07200 ] 
122906856   SREBF1; sterol regulatory element-binding protein 1 isoform X1 [KO:K07197 ] 
122908267   NDUFV3; NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial isoform X1 [KO:K03944 ] 
122908543   NDUFB4; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 [KO:K03960 ] 
122908712   PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922 ] [EC:2.7.1.153 ] 
122908719   NDUFB5; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial isoform X1 [KO:K03961 ] 
122908899   PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922 ] [EC:2.7.1.153 ] 
122909195   PPARG; peroxisome proliferator-activated receptor gamma isoform X1 [KO:K08530 ] 
122909517   NDUFA13; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 [KO:K11353 ] 
122909545   NDUFB7; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 [KO:K03963 ] 
122909588   PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649 ] 
122909803   NDUFA7; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 [KO:K03951 ] 
122909833   NDUFA11; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11 [KO:K03956 ] 
122909951   NDUFS7; NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial [KO:K03940 ] [EC:7.1.1.2 ] 
122911678   NDUFA3; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 [KO:K03947 ] 
122912064   TGFB1; transforming growth factor beta-1 proprotein isoform X1 [KO:K13375 ] 
122912281   SDHD; succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial isoform X1 [KO:K00237 ] 
122912907   NDUFS3; NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial [KO:K03936 ] [EC:7.1.1.2 ] 
122913199   NDUFS8; NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial isoform X1 [KO:K03941 ] [EC:7.1.1.2 ] 
122917290   NDUFA8; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 [KO:K03952 ] 
122917534   NDUFB6; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 [KO:K03962 ] 
122918121   FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389 ] 
122918234   IL6R; interleukin-6 receptor subunit alpha isoform X1 [KO:K05055 ] 
122918373   NDUFS2; NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial isoform X1 [KO:K03935 ] [EC:7.1.1.2 ] 
122918379   SDHC; succinate dehydrogenase cytochrome b560 subunit, mitochondrial [KO:K00236 ] 
122918946   PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649 ] 
122919183   NDUFC1; NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial [KO:K03967 ] 
 
Compound  
 
Reference  
 
  Authors  
Naik A, Kosir R, Rozman D
 
  Title  
Genomic aspects of NAFLD pathogenesis.
 
  Journal  
 
Reference  
 
  Authors  
Malaguarnera M, Di Rosa M, Nicoletti F, Malaguarnera L
 
  Title  
Molecular mechanisms involved in NAFLD progression.
 
  Journal  
 
Reference  
 
  Authors  
Seki E, Brenner DA, Karin M
 
  Title  
A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches.
 
  Journal  
 
Reference  
 
  Authors  
Tilg H, Moschen AR
 
  Title  
Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.
 
  Journal  
 
Reference  
 
  Authors  
Larter CZ, Farrell GC
 
  Title  
Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?
 
  Journal  
 
Reference  
 
  Authors  
Farrell GC, van Rooyen D, Gan L, Chitturi S
 
  Title  
NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.
 
  Journal  
 
Reference  
 
  Authors  
Shapiro H, Tehilla M, Attal-Singer J, Bruck R, Luzzatti R, Singer P
 
  Title  
The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease.
 
  Journal  
 
Reference  
 
  Authors  
Hotamisligil GS
 
  Title  
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease.
 
  Journal  
 
Reference  
 
  Authors  
Parekh S, Anania FA
 
  Title  
Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
 
  Journal  
 
Reference  
 
  Authors  
Schattenberg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE, Czaja MJ
 
  Title  
JNK1 but not JNK2 promotes the development of steatohepatitis in mice.
 
  Journal  
 
Reference  
 
  Authors  
Leung TM, Nieto N
 
  Title  
CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease.
 
  Journal  
 
Reference  
 
  Authors  
Zafrani ES
 
  Title  
Non-alcoholic fatty liver disease: an emerging pathological spectrum.
 
  Journal  
 
Reference  
 
  Authors  
Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ
 
  Title  
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.
 
  Journal  
 
Reference  
 
  Authors  
Begriche K, Igoudjil A, Pessayre D, Fromenty B
 
  Title  
Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.
 
  Journal  
 
Reference  
 
  Authors  
Leonarduzzi G, Scavazza A, Biasi F, Chiarpotto E, Camandola S, Vogel S, Dargel R, Poli G
 
  Title  
The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis.
 
  Journal  
 
Reference  
 
  Authors  
Malhi H, Kaufman RJ
 
  Title  
Endoplasmic reticulum stress in liver disease.
 
  Journal  
 
Reference  
 
  Authors  
Mantena SK, King AL, Andringa KK, Eccleston HB, Bailey SM
 
  Title  
Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases.
 
  Journal  
 
Reference  
 
  Authors  
Serviddio G, Sastre J, Bellanti F, Vina J, Vendemiale G, Altomare E
 
  Title  
Mitochondrial involvement in non-alcoholic steatohepatitis.
 
  Journal  
 
Reference  
 
  Authors  
Begriche K, Massart J, Robin MA, Bonnet F, Fromenty B
 
  Title  
Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease.
 
  Journal  
 
Related pathway  
nvs04141   Protein processing in endoplasmic reticulum 
nvs04920   Adipocytokine signaling pathway 
 
KO pathway